Studies on the role of acid sphingomyelinase and ceramide in the regulation of tumor necrosis factor alpha (TNFalpha)-converting enzyme activity and TNFalpha secretion in macrophages
- PMID: 20236926
- PMCID: PMC2898350
- DOI: 10.1074/jbc.M109.080671
Studies on the role of acid sphingomyelinase and ceramide in the regulation of tumor necrosis factor alpha (TNFalpha)-converting enzyme activity and TNFalpha secretion in macrophages
Abstract
Acid sphingomyelinase (ASMase) has been proposed to mediate lipopolysaccharide (LPS) signaling in various cell types. This study shows that ASMase is a negative regulator of LPS-induced tumor necrosis factor alpha (TNFalpha) secretion in macrophages. ASMase-deficient (asm(-/-)) mice and isolated peritoneal macrophages produce severalfold more TNFalpha than their wild-type (asm(+/+)) counterparts when stimulated with LPS, whereas the addition of exogenous ceramides or sphingomyelinase reduces the differences. The underlying mechanism for these effects is not transcriptional but post-translational. The TNFalpha-converting enzyme (TACE) catalyzes the maturation of the 26-kDa precursor (pro-TNFalpha) to an active 17-kDa form (soluble (s)TNFalpha). In mouse peritoneal macrophages, the activity of TACE was the rate-limiting factor regulating TNFalpha production. A substantial portion of the translated pro-TNFalpha was not processed to sTNFalpha; instead, it was rapidly internalized and degraded in the lysosomes. TACE activity was 2-3-fold higher in asm(-/-) macrophages as compared with asm(+/+) macrophages and was suppressed when cells were treated with exogenous ceramide and sphingomyelinase. Indirect immunofluorescence analyses revealed distinct TNFalpha-positive structures in the close vicinity of the plasma membrane in asm(-/-) but not in asm(+/+) macrophages. asm(-/-) cells also had a higher number of early endosomal antigen 1-positive early endosomes. Experiments that involved inhibitors of TACE, endocytosis, and lysosomal proteolysis suggest that in the asm(-/-) cells a significant portion of pro-TNFalpha was sequestered within the early endosomes, and instead of undergoing lysosomal proteolysis, it was recycled to the plasma membrane and processed to sTNFalpha.
Figures
![FIGURE 1.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2898350/bin/zbc0261016770001.gif)
![FIGURE 2.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2898350/bin/zbc0261016770002.gif)
![FIGURE 3.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2898350/bin/zbc0261016770003.gif)
![FIGURE 4.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2898350/bin/zbc0261016770004.gif)
![FIGURE 5.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2898350/bin/zbc0261016770005.gif)
![FIGURE 6.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2898350/bin/zbc0261016770006.gif)
![FIGURE 7.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2898350/bin/zbc0261016770007.gif)
![FIGURE 8.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2898350/bin/zbc0261016770008.gif)
![FIGURE 9.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2898350/bin/zbc0261016770009.gif)
Similar articles
-
Staphylococcus aureus α-Toxin Induces Inflammatory Cytokines via Lysosomal Acid Sphingomyelinase and Ceramides.Cell Physiol Biochem. 2017;43(6):2170-2184. doi: 10.1159/000484296. Epub 2017 Oct 25. Cell Physiol Biochem. 2017. PMID: 29069651
-
Ceramide kinase regulates the production of tumor necrosis factor α (TNFα) via inhibition of TNFα-converting enzyme.J Biol Chem. 2011 Dec 16;286(50):42808-17. doi: 10.1074/jbc.M111.310169. Epub 2011 Oct 18. J Biol Chem. 2011. PMID: 22009748 Free PMC article.
-
LPS-mediated septic shock is augmented in ceramide synthase 2 null mice due to elevated activity of TNFα-converting enzyme.FEBS Lett. 2015 Aug 4;589(17):2213-7. doi: 10.1016/j.febslet.2015.06.045. Epub 2015 Jul 13. FEBS Lett. 2015. PMID: 26183206
-
Solving the secretory acid sphingomyelinase puzzle: Insights from lysosome-mediated parasite invasion and plasma membrane repair.Cell Microbiol. 2019 Nov;21(11):e13065. doi: 10.1111/cmi.13065. Epub 2019 Jun 10. Cell Microbiol. 2019. PMID: 31155842 Free PMC article. Review.
-
The acid sphingomyelinase/ceramide pathway: biomedical significance and mechanisms of regulation.Curr Mol Med. 2010 Jul;10(5):454-66. doi: 10.2174/156652410791608225. Curr Mol Med. 2010. PMID: 20540705 Review.
Cited by
-
Nutritional roles and therapeutic potentials of dietary sphingomyelin in brain diseases.J Clin Biochem Nutr. 2024 May;74(3):185-191. doi: 10.3164/jcbn.23-97. Epub 2023 Dec 26. J Clin Biochem Nutr. 2024. PMID: 38799143 Free PMC article.
-
Acid sphingomyelinase as a pathological and therapeutic target in neurological disorders: focus on Alzheimer's disease.Exp Mol Med. 2024 Feb;56(2):301-310. doi: 10.1038/s12276-024-01176-4. Epub 2024 Feb 9. Exp Mol Med. 2024. PMID: 38337058 Free PMC article. Review.
-
Lipidomic assessment of the impact of Nannochloropsis oceanica microalga lipid extract on human skin keratinocytes exposed to chronic UVB radiation.Sci Rep. 2023 Dec 15;13(1):22302. doi: 10.1038/s41598-023-49827-2. Sci Rep. 2023. PMID: 38102403 Free PMC article.
-
Cannabidiol and Cannabigerol Modify the Composition and Physicochemical Properties of Keratinocyte Membranes Exposed to UVA.Int J Mol Sci. 2023 Aug 4;24(15):12424. doi: 10.3390/ijms241512424. Int J Mol Sci. 2023. PMID: 37569799 Free PMC article.
-
Adiponectin receptor agonist ameliorates cardiac lipotoxicity via enhancing ceramide metabolism in type 2 diabetic mice.Cell Death Dis. 2022 Mar 30;13(3):282. doi: 10.1038/s41419-022-04726-8. Cell Death Dis. 2022. PMID: 35351872 Free PMC article.
References
-
- Feldmann M., Maini S. R. (2008) Immunol. Rev. 223, 7–19 - PubMed
-
- Sethi G., Sung B., Aggarwal B. B. (2008) Front. Biosci. 13, 5094–5107 - PubMed
-
- Zentella A., Manogue K., Cerami A. (1991) Prog. Clin. Biol. Res. 367, 9–24 - PubMed
-
- Fujihara M., Muroi M., Tanamoto K., Suzuki T., Azuma H., Ikeda H. (2003) Pharmacol. Ther. 100, 171–194 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous